CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing new sonosensitizers for sonodynamic therapy, which uses ultrasound to activate compounds that generate reactive oxygen species for cancer treatment. The aim is to create effective treatments that work even in low-oxygen environments, enhancing the therapeutic potential of this innovat…
Sonodynamic therapy (SDT) is emerging as a promising alternative to conventional chemotherapy and light-activated therapies.
Unlike other approaches, which often suffer from limited tissue penetration or severe systemic toxicity, SDT capitalizes on the unique properties of ultrasound to activate specialized compounds known as sonosensitizers.
Upon exposure to ultrasound (up to 10 cm depth), these sonosensitizers generate reactive oxygen species (ROS) through cavitation-driven processes, thereby…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
